Glucose counterregulatory failure and hypoglycaemia unawareness frequently
complicate treatment of Type 1 diabetes mellitus, especially when aiming fo
r intensive metabolic control. Since tight metabolic control reduces microv
ascular long-term complications in Type 2 diabetes mellitus, the integrity
of glucose counterregulation in Type 2 diabetic patients is important. Usin
g a Medline search, we identified 12 studies in which counterregulatory res
ponses to insulin-induced hypoglycaemia were compared between Type 2 diabet
ic patients and appropriate controls. A review of these studies showed that
some patients with Type 2 diabetes mellitus develop mild counterregulatory
dysfunction and reduced awareness of insulin-induced hypoglycaemia. Some s
tudies suggested an association between counterregulatory impairment and in
tensity of metabolic control. We speculate that the relatively low frequenc
y of (severe) hypoglycaemic events in Type 2 diabetes may explain why gluco
se counterregulation remains unaffected in most patients. We hypothesize th
at residual Beta-cell reserve and insulin resistance provide protection aga
inst severe hypoglycaemia and limit impaired counterregulation.